Loading clinical trials...
Loading clinical trials...
Disruption of an atherosclerotic plaque is responsible for at least two-thirds of acute coronary syndrome. Thus, identification of plaques vulnerable to rupture has become important. The natural histo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hiroshima University
NCT07669168 · Health Services Accessibility, Rural Health, and more
NCT07256249 · Cardiovascular Diseases
NCT07660419 · Coronary Artery Disease (CAD), Coronary Stenosis
NCT07613294 · Atherosclerosis, Cardiovascular Diseases, and more
NCT05867381 · Air Pollution, Atherosclerosis
Hiroshima University Graduate School of Biomedical and Health Sciences, Department of Cardiovascular Medicine
Hiroshima, Hiroshima
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions